This site is intended for healthcare professionals and the scientific community. The aim of this website is to provide access and support regarding scientific information and research about certain strains, whether included in Danone products or not, and does not have any promotional purpose.
Therefore, the content of this website should not, in any manner, be construed as a health claim in the sense of Regulation (EC) No. 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods.
This website is updated regularly to ensure that the most recent scientific information is accessible.
Danone research makes public the clinical studies related to its exclusive strains
Danone Research, Danone’s global R&D community gathering about 1,200 collaborators, has aimed to provide a direct access to the publications of the clinical studies carried out over the last 20 years related to its exclusive strains: more than 40 publications of clinical studies.
Danone Research performs most of its clinical trials with independent experts. The same level of scientific rigour is used for the studies conducted by Danone and those conducted by the pharmaceutical industry. Our studies are compliant with Good Clinical Practices (GCP), an international scientific and ethical quality standard for the design, implementation, registration, documentation and archiving of studies conducted on human beings.
Danone Research devotes significant funds to the strain research.
Starting with an exclusive collection of 4000 strains, the research team’s work involves defining these strains from a molecular point of view, characterising them, identifying their range of properties, then introducing the selected bacteria into a product and ensuring it can be produced on an industrial scale.
Throughout the work, the teams use the most recent techniques in genomics and robotics; they develop high-level collaborations like for example with Washington University (USA), Pasteur Institute, Wageningen University (Netherlands), the Lawson Institute (Canada) or INRA (France).